Literature DB >> 26053290

An individualized diagnostic approach based on guidelines for chronic urticaria (CU).

A M Giménez-Arnau1, C Grattan2, T Zuberbier3, E Toubi4.   

Abstract

Chronic urticaria (CU), defined as the spontaneous or inducible appearance of hives, angioedema or both for 6 weeks or more, presents with a number of subtypes which all substantially impair patients' quality of life (QoL). International urticaria guidelines give clear recommendations on workup and treatment but the occurrence of CU with multiple causes and triggers (sometimes with more than one subtype occurring in a single patient) presents challenges for an individualized assessment by physicians. This review summarizes recent guidance on the classification, diagnosis and assessment of CU subtypes and discusses how currently available patient assessment tools and laboratory tests can be used in clinical practice as part of an individualized patient management plan.
© 2015 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2015        PMID: 26053290     DOI: 10.1111/jdv.13196

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

Review 1.  Pharmacologic Management of Chronic Urticaria in Pediatric Patients: The Gap Between Guidelines and Practice.

Authors:  Paul V Williams
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

2.  [Bradykinin-induced angioedema: Definition, pathogenesis, clinical presentation, diagnosis and therapy].

Authors:  J Hahn; M Bas; T K Hoffmann; J Greve
Journal:  HNO       Date:  2015-12       Impact factor: 1.284

3.  OSMR gene effect on the pathogenesis of chronic autoimmune Urticaria via the JAK/STAT3 pathway.

Authors:  Xiao-Yan Luo; Qun Liu; Huan Yang; Qi Tan; Li-Qiang Gan; Fa-Liang Ren; Hua Wang
Journal:  Mol Med       Date:  2018-06-05       Impact factor: 6.354

4.  IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.

Authors:  Ana M Giménez-Arnau; Clara Ribas-Llauradó; Nasser Mohammad-Porras; Gustavo Deza; Ramón M Pujol; Ramón Gimeno
Journal:  Clin Transl Allergy       Date:  2022-02-01       Impact factor: 5.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.